402 related articles for article (PubMed ID: 35734904)
1. Age-related fertility decline: is there a role for elective ovarian tissue cryopreservation?
Kasaven LS; Saso S; Getreu N; O'Neill H; Bracewell-Milnes T; Shakir F; Yazbek J; Thum MY; Nicopoullos J; Ben Nagi J; Hardiman P; Diaz-Garcia C; Jones BP
Hum Reprod; 2022 Aug; 37(9):1970-1979. PubMed ID: 35734904
[TBL] [Abstract][Full Text] [Related]
2. Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey.
Kasaven LS; Mitra A; Ostrysz P; Theodorou E; Murugesu S; Yazbek J; Bracewell-Milnes T; Ben Nagi J; Jones BP; Saso S
Hum Reprod; 2023 Dec; 38(12):2478-2488. PubMed ID: 37816663
[TBL] [Abstract][Full Text] [Related]
3. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women.
Brouillet S; Ferrieres-Hoa A; Fournier A; Martinez G; Bessonnat J; Gueniffey A; Gala A; Loup V; Hamamah S
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33165323
[TBL] [Abstract][Full Text] [Related]
5. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
6. Elective oocyte cryopreservation for deferred childbearing.
Goldman KN; Grifo JA
Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):458-464. PubMed ID: 27672732
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Tissue Oocyte-In Vitro Maturation for Fertility Preservation.
Segers I; Mateizel I; Wouters K; Van Moer E; Anckaert E; De Munck N; De Vos M
J Vis Exp; 2024 May; (207):. PubMed ID: 38829044
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
9. Oocyte vitrification for elective fertility preservation: a SWOT analysis.
Gil-Arribas E; Blockeel C; Pennings G; Nekkebroeck J; Velasco JAG; Serna J; De Vos M
Reprod Biomed Online; 2022 Jun; 44(6):1005-1014. PubMed ID: 35304091
[TBL] [Abstract][Full Text] [Related]
10. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation in girls and young women.
Anderson RA; Wallace WH
Clin Endocrinol (Oxf); 2011 Oct; 75(4):409-19. PubMed ID: 21575025
[TBL] [Abstract][Full Text] [Related]
12. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
13. [Fertility preservation in oncology].
Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
[TBL] [Abstract][Full Text] [Related]
14. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
15. Oocyte vitrification for elective fertility preservation: the past, present, and future.
Gunnala V; Schattman G
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):59-63. PubMed ID: 27922944
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
17. Vitrification of human oocytes.
Coello A; Pellicer A; Cobo A
Minerva Ginecol; 2018 Aug; 70(4):415-423. PubMed ID: 29527869
[TBL] [Abstract][Full Text] [Related]
18. Social Freezing: Pressing Pause on Fertility.
Varlas VN; Bors RG; Albu D; Penes ON; Nasui BA; Mehedintu C; Pop AL
Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360381
[TBL] [Abstract][Full Text] [Related]
19. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.
Dolmans MM; Donnez J
Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in fertility preservation.
Dolmans MM; Manavella DD
J Obstet Gynaecol Res; 2019 Feb; 45(2):266-279. PubMed ID: 30246274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
